TRXADE HEALTH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.31 USD | +0.80% |
|
-1.87% | +21.43% |
| 22/04 | TRxADE HEALTH, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 06/03 | Top Midday Gainers | MT |
| Sales 2022 | 11.45M 955M | Sales 2023 | 8.27M 690M | Capitalization | 6.48M 540M |
|---|---|---|---|---|---|
| Net income 2022 | -3M -250M | Net income 2023 | -17M -1.42B | EV / Sales 2022 | 0.37 x |
| Net Debt 2022 | 450K 37.54M | Net Debt 2023 | 6.95M 580M | EV / Sales 2023 | 1.62 x |
| P/E ratio 2022 |
-0.98
x | P/E ratio 2023 |
-0.22
x | Employees | 8 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 75.94% |
More Fundamentals
* Assessed data
More news
Latest transcript on TRxADE HEALTH, Inc.
More recommendations
More press releases
| 1 day | +0.80% | ||
| 1 week | -1.87% | ||
| Current month | -38.38% | ||
| 1 month | -32.00% | ||
| 3 months | +43.47% | ||
| 6 months | +3.44% | ||
| Current year | +21.43% |
1 week
5.82
7.08
1 month
5.8210.74
Current year
3.6944.56
1 year
3.6944.56
3 years
3.69162.30
5 years
3.69174.00
10 years
3.69265.50
| Managers | Title | Age | Since |
|---|---|---|---|
Prashant Patel
FOU | Founder | 49 | 15/05/15 |
| Chief Executive Officer | 53 | 15/05/15 | |
Jeff Davis
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 15/05/15 | |
Michael Peterson
BRD | Director/Board Member | 62 | 24/16/24 |
A. Newell
BRD | Director/Board Member | 66 | 30/22/30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 6.31 | +0.80% | 14,603 |
| 25/24/25 | 6.26 | -2.95% | 20,336 |
| 24/24/24 | 6.45 | -0.77% | 16,467 |
| 23/24/23 | 6.5 | -2.40% | 9,925 |
| 22/24/22 | 6.66 | +3.58% | 28,181 |
Delayed Quote Nasdaq, April 27, 2024 at 02:00 am IST
More quotes
TRxADE Health, Inc. provides a technology-enabled health services platform. The Company is focused on digitalizing the retail pharmacy and health services experience by optimizing drug procurement, the prescription journey, access to physicians in the patientâs home and patient engagement in the United States. The Companyâs segments include Trxade, Inc., Integra Pharma Solutions, LLC (IPS) and Superlatus. Trxade, Inc. segment provides a web-based pharmaceutical marketplace platform-business to business (B2B) sales. IPS is a licensed pharmaceutical wholesaler and sells brand, generic and non-drug products to customers. The Superlatus segment holds Sapientiaâs intellectual property for advanced food extrusion technology and The Urgent Company, which is a manufacturer of ice cream that is animal product-free, vegan, lactose-free, and made with plant-B2B sales. Its subsidiaries include Community Specialty Pharmacy, LLC, Alliance Pharma Solutions, LLC, Bonum Health, LLC and others.
Sector
Internet Services
Calendar
22/07/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +21.43% | 8.87M | |
| +18.66% | 414B | |
| +15.27% | 242B | |
| +12.15% | 144B | |
| +20.63% | 104B | |
| +17.19% | 83.87B | |
| +54.11% | 57.64B | |
| +33.59% | 53.37B | |
| +6.02% | 37.83B | |
| +15.88% | 32.51B |
- Stock Market
- Equities
- MEDS Stock
